Shares in Becton Dickinson (NYSE: BDX) held steady today after the company beat expectations on Wall Street with its second-quarter results. The Franklin Lakes, N.J.-based company swung to a net loss of -$50 million, or -19¢ per share, on sales of $4.22 billion for the 3 months ended March 31, up 42% compared with the same period […]
Becton Dickinson
DHS warns on cyber vulnerability with BD’s Pyxis drug-dispensing devices
An array of medication-management systems from Becton Dickinson (NYSE: BDX) are vulnerable to the industry-wide KRACK key-reinstallation cyber attack, according to the company and to the Dept. of Homeland Security. The glitch, which was first reported last year, is a vulnerability in the WPA2 protocol for securing Wi-Fi that can imperil the confidentiality and integrity of communication […]
Manufacturing fault prompts BD to recall blood collection tubes
Becton Dickinson‘s (NYSE: BDX) life sciences division issued a recall last month for some of its blood collection tubes, citing a manufacturing flaw that resulted in devices without sufficient additive. The company explained that an internal investigation found that Vacutainer Citrate Plus tubes with too little additive led to falsely-shortened clotting time and could impact patient […]
BD finds chemical from blood collection tube interferes with Magellen lead test
Studies conducted by Becton Dickinson (NYSE: BDX) found that a chemical present in its Vacutainer blood collection tubes interfered with lead tests made by Magellan Diagnostics. The FDA first warned consumers in May of 2017 that Magellan’s lead tests may provide inaccurate results when used with blood drawn from the vein and held in BD’s blood collection […]
Meet 5 companies developing novel drug-delivery devices
At the 7th annual Partnership Opportunities in Drug Delivery event, presented by The Conference Forum, device companies gathered to tout their drug-delivery technologies and learn from each other’s mistakes and successes. Among them were needle-free injectors, patch pumps, auto-injectors and other novel delivery devices. Moderated by Pfizer‘s (NYSE:PFE) senior director of device strategy, Mathias Romacker, […]
These speedy BD robot arms store and retrieve medications in seconds
It’s not difficult to see hospitals and pharmacies challenged by dispensing thousands of drugs with speed and accuracy. As the number of drugs rises, so do security issues. To address both, the Rowa Division of BD in Germany has introduced two machines. The Rowa Vmax provides for the automatic storage and retrieval of boxed pharmaceuticals […]
BD launches fully-automated diagnostic to fight antimicrobial resistance in Europe
Becton Dickinson (NYSE: BDX) today launched the first automated phenotypic diagnostic test for infections caused by carbapenemase-producing organisms. The new BD Phoenix CPO test is available as part of the BD Phoenix automated microbiology system in Europe, the company said, and is designed to help hospitals detect and contain infections caused by CPOs. Carbapenemase-producing organisms are resistant […]
BD launches ultra-fine 6mm needle for injection pen devices
Becton Dickinson (NYSE: BDX) introduced today its ultra-fine micro pen needle for use with injection pen devices. The 6 mm x 32G pen needle is compatible with leading pen injection devices, the company said. “We added the BD Ultra-Fine micro pen needles to ensure BD has a comprehensive portfolio that provide options to patients and reinforces BD’s commitment […]
BD recalls select Plastipak catheter tip syringes over leakage issues
Becton Dickinson (NYSE: BDX) is initiating a voluntary product recall for its 100ml Plastipak catheter tip syringes over leakage issues the company caught during testing. The Franklin Lakes, N.J. company discovered that the devices, which are labeled with a 5-year expiration date, were found to be failing during routine real-time stability tests, beginning at the […]
BD wins 510(k) for intestinal bacteria diagnostic
Becton Dickinson (NYSE:BDX) said today that it won 510(k) clearance from the FDA for its molecular test that detects harmful intestinal bacteria causing infectious diarrhea. With the approval of its BD Max extended enteric bacteria panel, the company said the majority of pathogens causing acute gastroenteritis can be detected on its automated BD Max molecular […]
